Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Terminated"
topic_facet:"Lymphoma"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&filter%5B%5D=topic_facet%3A%22Lymphoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&filter%5B%5D=topic_facet%3A%22Lymphoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&filter%5B%5D=topic_facet%3A%22Lymphoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (553)
1
A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma : A Phase I Open-Label Study of the Safety and Tolerability of ATG-019, a Dual Inhibitor of PAK4 and NAMPT, in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) Diffuse Large-cell B-cell Lymphoma (DLBCL) : A Phase 2 Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of XmAb13676 (Plamotamab) Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas : A Phase 1, Open-label, Dose Finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90011 in Subjects With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss : A Phase 1 Study of AG-270 in the Treatment of Subjects With Advanced Solid Tumors or Lymphoma With Homozygous Deletion of MTAP
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia : A Two-Stage Phase 1 Open-Label Study of huJCAR014, CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells Bearing a Human Binding Domain, in Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Acute Lymphocytic Leukemia
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Radiation Post-CAR T in Refractory Lymphoma : Radiation Therapy To Enhance CAR T Efficacy Early in Post-CAR T Cell Therapy Refractory Lymphoma: A Pilot Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma : A Multicentre Open-label Dose Escalation Tiral of Zanolimumab in Combination With CHOP Chemotherapy in Patients With CD4 Positive Non-cutaneous Peripheral T-cell Lymphoma With Nodal Involvement.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma : SYMPHONY-II: A Phase II Open-Label, Multicenter Trial of Oral Tazemetostat in Combination With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma : A Phase 1, First-in-Human, Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With Relapsed / Refractory Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma : Rituximab With or Without Ibrutinib for Untreated Patients With Advanced Follicular Lymphoma in Need of Therapy. A Randomized, Double-blinded, SAKK and NLG Collaborative Phase II Trial.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[56]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Recruitment Status: Terminated
Filter aufheben
Thema: Lymphoma
Medienart
553
Aufsätze
553
E-Artikel
553
E-Ressourcen
Zeitschriftentitel
553
ClinicalTrials.gov
Thema
553
610
Lymphoma
Recruitment Status: Terminated
553
Study Type: Interventional
229
Phase: Phase 2
181
Lymphoma, Non-Hodgkin
160
Phase: Phase 1
140
Lymphoma, B-Cell
134
Leukemia
121
Lymphoma, Large B-Cell, Diffuse
89
Leukemia, Lymphocytic, Chronic, B-Cell
85
Lymphoma, Follicular
83
Leukemia, Lymphoid
78
Lymphoma, Mantle-Cell
68
Lymphoma, T-Cell
58
Precursor Cell Lymphoblastic Leukemia-Lymphoma
57
Hodgkin Disease
47
Multiple Myeloma
42
Medical Condition: Lymphoma
41
Phase: Phase 1/Phase 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
245
2020-
298
2010-2019
10
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
553
Englisch
Haven't found what you're looking for?
Wird geladen...